ArticleJournal of thrombosis and thrombolysis2021

Monitoring the therapeutic effect of caplacizumab by von Willebrand Factor activity assays: Proceed with caution.

Sean G Yates et al.PubMed ↗Publisher ↗

No numbers read from the abstract.